Rapidly growing Swiss biopharmaceuticals group Lonza has launched a feasibility study for an office and laboratory relocation that could spark one of the South East's largest campus requirements, CoStar News can reveal.
Rapidly growing Swiss biopharmaceuticals group Lonza has launched a feasibility study for an office and laboratory relocation that could spark one of the South East's largest campus requirements, CoStar News can reveal.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In